Related Experiment Video
Updated: Mar 28, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
Myocardial infarction accelerates atherosclerosis
Partha Dutta1, Gabriel Courties, Ying Wei
1Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Insights
Myocardial infarction and stroke worsen atherosclerosis by mobilizing stem cells to produce more monocytes. This discovery offers new ways to treat cardiovascular disease progression.
Area of Science:
- Cardiovascular Science
- Immunology
- Hematology
Background:
- Myeloid cells contribute to atherosclerotic plaque rupture, leading to myocardial infarction and stroke.
- Recurrent cardiovascular events are common in survivors due to unknown mechanisms.
Purpose of the Study:
- To investigate how systemic responses to ischemic injury, such as myocardial infarction or stroke, affect chronic atherosclerosis.
- To identify the source of increased monocyte recruitment in atherosclerotic plaques after ischemic events.
Main Methods:
- Utilized Apoe-/- mice models subjected to myocardial infarction or stroke.
- Analyzed atherosclerotic lesion size and morphology.
- Investigated monocyte recruitment and hematopoietic stem and progenitor cell mobilization.
- Examined the role of sympathetic nervous system signaling.
Main Results:
- Ischemic injury accelerated atherosclerosis, resulting in larger, more advanced lesions in Apoe-/- mice.
- Monocyte recruitment significantly increased in plaques weeks after myocardial infarction or stroke.
- Myocardial infarction triggered the release of hematopoietic stem and progenitor cells from bone marrow via sympathetic nervous system signaling.
- These progenitors migrated to the spleen, leading to sustained elevated monocyte production.
Conclusions:
- Systemic response to ischemic injury exacerbates atherosclerosis by boosting monocyte production.
- Sympathetic nervous system signaling plays a key role in mobilizing hematopoietic stem and progenitor cells after myocardial infarction.
- This study reveals a novel mechanism linking ischemic events to accelerated atherogenesis and suggests potential therapeutic targets.
Abstract:
During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaques in the arterial wall and cause their rupture, thus triggering myocardial infarction and stroke. Survivors of acute coronary syndromes have a high risk of recurrent events for unknown reasons. Here we show that the systemic response to ischaemic injury aggravates chronic atherosclerosis. After myocardial infarction or stroke, Apoe-/- mice developed larger atherosclerotic lesions with a more advanced morphology. This disease acceleration persisted over many weeks and was associated with markedly increased monocyte recruitment. Seeking the source of surplus monocytes in plaques, we found that myocardial infarction liberated haematopoietic stem and progenitor cells from bone marrow niches via sympathetic nervous system signalling. The progenitors then seeded the spleen, yielding a sustained boost in monocyte production. These observations provide new mechanistic insight into atherogenesis and provide a novel therapeutic opportunity to mitigate disease progression.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Myocarditis I: Introduction
Atherosclerosis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Inflammation

